Skip to main content
Caplight Logo









EXORPHIA Inc.

EXORPHIA Inc.

Private
TokyoHealthcare & Life Scienceshttps://exorphia.com/

Last Round

Grant

Dec 16, 2024

Total Funding Raised

$10.4M

Company Overview

EXORPHIA Inc. is a biotechnology company that develops innovative exosome-based therapeutics to address unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

exosome therapeuticsextracellular vesiclesEVsdrug discoveryregenerative medicinecell-free therapyengineered EVsdrug licensinganti-inflammatory therapeuticsanti-fibrotic therapeuticsexosome purificationinfertility treatmentlung disordersin vitro fertilizationIVFmesenchymal stem cellsMSCsveterinary medicinenasal vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EXORPHIA Inc. Comparables

Compare EXORPHIA Inc. with similar companies based on industry and business-model similarity.

EXORPHIA Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EVerMed, Inc.
87%
BREXOGEN Inc.
85%
SHIFTBIO
79%

EXORPHIA Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2024
VC RoundDec 1, 2024
StrategicMar 1, 2024
Series AJul 1, 2023
Pre SeedMay 19, 2022
Seed
Apr 12, 2021

EXORPHIA Inc. Investors

Notable investors and investment history

EXORPHIA Inc. investors
InvestorRounds
Coral CapitalSeries A
Keio Innovation InitiativeSeries A, Pre Seed
New Energy and Industrial Technology Development OrganizationGrant
Coral CapitalVC Round
D3 LLCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2025

    Monthly visitors increased 116% MoM.

  • Dec 16, 2024

    $1.07M grant received from New Energy and Industrial Technology Development Organization.

EXORPHIA Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EXORPHIA Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EXORPHIA Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range9
Year Founded2019
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?